Menlo Therapeutics Inc. (MNLO) Prices 7M Share IPO at $17/Sh

Menlo Therapeutics Inc. (NASDAQ: MNLO) today announced the pricing of the Company’s initial public offering of 7,000,000 shares of common stock at a public offering price of $17.00 per share, before underwriting discounts. All of the shares of common stock are being offered by Menlo. The Company has also granted the underwriters a 30-day option to purchase from the Company an additional 1,050,000 shares of common stock at the initial public offering price, less the underwriting discount. Menlo’s common stock has been approved for listing on The Nasdaq Global Select Market and is expected to begin trading under the ticker symbol “MNLO” on January 25, 2018. The offering is expected to close on January 29, 2018, subject to customary closing conditions.

Jefferies LLC, Piper Jaffray & Co. and Guggenheim Securities, LLC are acting as joint book running managers for the proposed offering. JMP Securities is acting as the lead manager for this offering.

You May Also Be Interested In

• Goldman, BofA vie to manage Anthropic employee wealth post-IPO - report
• Agomab adds two members to its board of directors
• Rainier Acquisition Corporation Announces Separation of Its Class A Ordinary Shares and Warrants on Nasdaq, Commencing September 14, 2026